Latest news
FMT Shows Promise for Peanut Allergy Tolerance in Phase I Trial - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Fri, 07 Aug 2026 03:24:01 GMTargenx partners with Monash University and Myostellar to develop muscular therapies - PharmaDispatchPharmaDispatch · Thu, 06 Aug 2026 20:37:30 GMTargenx to acquire Forte Biosciences for $2.2 billion, strengthens immunology pipeline - Indian Pharma PostIndian Pharma Post · Wed, 29 Jul 2026 06:33:48 GMTArgenx Acquires Forte Biosciences in 2.2 Billion Dollar Deal - sekbernews.idsekbernews.id · Tue, 28 Jul 2026 20:23:00 GMTargenx Acquires Forte Biosciences for $2.2 Billion to Expand Immunology Portfolio - sekbernews.idsekbernews.id · Tue, 28 Jul 2026 10:27:30 GMTArgenx Expands Immunology Portfolio with $2.2B Buyout of Forte Biosciences - Genetic Engineering and Biotechnology NewsGenetic Engineering and Biotechnology News · Tue, 28 Jul 2026 07:00:00 GMTargenx Expands Immunology Pipeline with Forte Biosciences Acquis - GuruFocusGuruFocus · Mon, 27 Jul 2026 15:30:37 GMTargenx to Acquire Forte Biosciences in $2.2 Billion Deal to Expand Autoimmune Pipeline - citybizcitybiz · Mon, 27 Jul 2026 12:46:29 GMT